v3.26.1
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2026
Summary of Significant Accounting Policies  
Summary of net revenue by product category

The following table summarizes net revenue by product category for the three months ended March 31, 2026 and 2025:

Three Months Ended

March 31, 

2026

2025

Diabetes

$

185,786

$

187,360

Sleep therapy

166,922

181,859

Home respiratory therapy

97,179

108,606

Ostomy

51,336

49,499

Wound care

39,402

46,646

Urology

29,790

28,143

Other

 

57,365

71,771

Net revenue

$

627,780

$

673,884

The following table summarizes net revenue by payor type for the three months ended March 31, 2026 and 2025:

Three Months Ended

March 31, 

2026

2025

Commercial payors (1)

$

493,206

$

543,528

Medicare

125,715

120,330

Medicaid

8,859

10,026

Net revenue

$

627,780

$

673,884

(1) Commercial payors includes revenue from Medicare Advantage plans.

Schedule of cost of revenue

Three Months Ended

March 31, 

2026

  ​ ​ ​

2025

Cost of product sold

$

315,392

$

317,389

Patient service equipment depreciation

28,889

31,683

Other costs

5,471

5,570

Cost of net revenue

$

349,752

$

354,642